BRITISH AMERN TOB PLC shareholders Q2 2024

BRITISH AMERN TOB PLC's ticker is BTI and the CUSIP is 110448107. A total of 553 filers reported holding BRITISH AMERN TOB PLC in Q2 2024. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

BRITISH AMERN TOB PLC shareholders Q2 2024
NameSharesValueWeighting ↓
JANICZEK WEALTH MANAGEMENT, LLC 1,178$37,1060.01%
FMR LLC 4,236,681$131,040,5380.01%
Bogart Wealth, LLC 5,197$160,7430.01%
Forum Financial Management, LP 15,071$466,1470.01%
Aspire Private Capital, LLC 1,057$32,6820.01%
MISSION WEALTH MANAGEMENT, LP 8,826$272,9800.01%
Concord Wealth Partners 1,227$37,9510.01%
WHITTIER TRUST CO 14,927$461,6790.01%
PRINCIPAL SECURITIES, INC. 8,562$264,8340.01%
Larson Financial Group LLC 3,549$109,7710.01%
Parallel Advisors, LLC 8,989$278,0230.01%
Blue Trust, Inc. 17,750$541,3760.01%
Mutual Advisors, LLC 6,619$235,1220.01%
DIMENSIONAL FUND ADVISORS LP 848,546$26,253,5350.01%
Invesco Ltd. 1,104,517$34,162,7110.01%
GREENLEAF TRUST 20,835$644,4270.01%
HOLLENCREST CAPITAL MANAGEMENT 4,600$142,2780.01%
INGALLS & SNYDER LLC 4,630$1430.01%
Parkside Financial Bank & Trust 1,247$38,5700.01%
GTS SECURITIES LLC 87,900$2,718,7470.01%
About BRITISH AMERN TOB PLC

British American Tobacco (BAT) is a multinational tobacco company headquartered in London, UK. The company is one of the largest tobacco companies in the world, with a presence in over 180 countries. BAT is known for its portfolio of popular cigarette brands, including Dunhill, Lucky Strike, and Pall Mall.

In recent years, BAT has been focusing on expanding its portfolio beyond traditional tobacco products. The company has invested heavily in developing and marketing new products, such as e-cigarettes and heated tobacco products. These products are seen as a way for the company to diversify its revenue streams and adapt to changing consumer preferences.

Despite facing regulatory challenges in many markets, BAT has continued to perform well financially. In 2020, the company reported revenue of £25.8 billion and a net profit of £5.2 billion. The company's strong financial performance has allowed it to continue investing in research and development, as well as expanding its presence in emerging markets.

However, BAT has also faced criticism from public health advocates and anti-tobacco groups. These groups argue that the company's products are harmful to public health and that the company has engaged in unethical marketing practices in the past.

Overall, BAT remains a major player in the global tobacco industry, with a strong portfolio of brands and a growing presence in new product categories. However, the company will need to navigate a challenging regulatory environment and address concerns about the health impacts of its products in order to continue growing in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists BRITISH AMERN TOB PLC's shareholders in Q2 2024. To view BRITISH AMERN TOB PLC's shareholder history, click here.